143 related articles for article (PubMed ID: 18085675)
1. Application of the adult international germ cell classification system to pediatric malignant non-seminomatous germ cell tumors: a report from the Children's Oncology Group.
Frazier AL; Rumcheva P; Olson T; Giller R; Cushing B; Cullen J; Marina N; London WB;
Pediatr Blood Cancer; 2008 Apr; 50(4):746-51. PubMed ID: 18085675
[TBL] [Abstract][Full Text] [Related]
2. Incorporating age into International Germ Cell Consensus Classification (IGCCC): a time to move forward?
Abdel-Rahman O
Expert Rev Anticancer Ther; 2018 Jan; 18(1):101-105. PubMed ID: 29115166
[TBL] [Abstract][Full Text] [Related]
3. Contemporary North-American population-based validation of the International Germ Cell Consensus Classification for metastatic germ cell tumors of the testis.
Mazzone E; Knipper S; Mistretta FA; Tian Z; Palumbo C; Soulieres D; De Cobelli O; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
World J Urol; 2020 Jun; 38(6):1535-1544. PubMed ID: 31463562
[TBL] [Abstract][Full Text] [Related]
4. Identification of a subgroup with worse prognosis among patients with poor-risk testicular germ cell tumor.
Kojima T; Kawai K; Tsuchiya K; Abe T; Shinohara N; Tanaka T; Masumori N; Yamada S; Arai Y; Narita S; Tsuchiya N; Habuchi T; Nishiyama H
Int J Urol; 2015 Oct; 22(10):923-7. PubMed ID: 26094715
[TBL] [Abstract][Full Text] [Related]
5. Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.
Olofsson SE; Nodin B; Gaber A; Eberhard J; Uhlén M; Jirström K; Jerkeman M
PLoS One; 2015; 10(3):e0121300. PubMed ID: 25811459
[TBL] [Abstract][Full Text] [Related]
6. Revised risk classification for pediatric extracranial germ cell tumors based on 25 years of clinical trial data from the United Kingdom and United States.
Frazier AL; Hale JP; Rodriguez-Galindo C; Dang H; Olson T; Murray MJ; Amatruda JF; Thornton C; Arul GS; Billmire D; Shaikh F; Pashankar F; Stoneham S; Krailo M; Nicholson JC
J Clin Oncol; 2015 Jan; 33(2):195-201. PubMed ID: 25452439
[TBL] [Abstract][Full Text] [Related]
7. The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3).
Seidel C; Daugaard G; Tryakin A; Necchi A; Cohn-Cedermark G; Ståhl O; Hentrich M; Brito M; Albany C; Taza F; Gerl A; Oechsle K; Oing C; Bokemeyer C
Urol Oncol; 2019 Nov; 37(11):809.e19-809.e25. PubMed ID: 31494007
[TBL] [Abstract][Full Text] [Related]
8. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic disease.
Gerl A; Clemm C; Lamerz R; Mann K; Wilmanns W
Eur J Cancer; 1993; 29A(7):961-5. PubMed ID: 7684597
[TBL] [Abstract][Full Text] [Related]
10. A new prognostic model for testicular germ cell tumours.
von Eyben FE; Madsen EL; Fritsche H; Suciu G; Liu F; Amato R
APMIS; 2003 Jan; 111(1):100-5; discussion 105. PubMed ID: 12752246
[TBL] [Abstract][Full Text] [Related]
11. Effect of the timing of orchiectomy on survival in patients with metastatic germ cell tumors of testis.
Fedyanin M; Tryakin A; Bulanov A; Fainshtein I; Zakharova T; Matveev V; Garin A; Tjulandin S
Urol Oncol; 2014 Jan; 32(1):32.e27-33. PubMed ID: 23628310
[TBL] [Abstract][Full Text] [Related]
12. Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
Hartmann JT; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Bokemeyer C
Ann Oncol; 2002 Jul; 13(7):1017-28. PubMed ID: 12176779
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection and outcome of malignant ovarian germ cell tumors in children-a national multicentric study compared to international results.
Elgendy A; Mostafa M; Salem MA; Ali A; Khairi A; Shehata S
Pediatr Surg Int; 2020 Sep; 36(9):1067-1075. PubMed ID: 32681191
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with stage II and III nonseminomatous germ cell tumors: results of a single center.
Ataergin S; Ozet A; Arpaci F; Kilic S; Beyzadeoglu M; Komurcu S
Indian J Cancer; 2007; 44(1):6-11. PubMed ID: 17401218
[TBL] [Abstract][Full Text] [Related]
15. Malignant ovarian germ cell tumors: clinico-pathological presentation and survival outcomes.
Tangjitgamol S; Hanprasertpong J; Manusirivithaya S; Wootipoom V; Thavaramara T; Buhachat R
Acta Obstet Gynecol Scand; 2010; 89(2):182-9. PubMed ID: 19961281
[TBL] [Abstract][Full Text] [Related]
16. α-Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium.
O'Neill AF; Xia C; Krailo MD; Shaikh F; Pashankar FD; Billmire DF; Olson TA; Amatruda JF; Villaluna D; Huang L; Malogolowkin M; Rodriguez-Galindo C; Frazier AL
Cancer; 2019 Oct; 125(20):3649-3656. PubMed ID: 31355926
[TBL] [Abstract][Full Text] [Related]
17. Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors: Implications for clinical practice, trial design, and molecular interrogation.
Raggi D; Mariani L; Giannatempo P; Lo Vullo S; Giardiello D; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Maffezzini M; Calareso G; Magni M; Di Nicola M; Verzoni E; Grassi P; Procopio G; De Braud F; Pizzocaro G; Salvioni R; Necchi A
Urol Oncol; 2015 Jul; 33(7):332.e19-24. PubMed ID: 25985712
[TBL] [Abstract][Full Text] [Related]
18. Lowered Cisplatin Dose and No Bleomycin in the Treatment of Pediatric Germ Cell Tumors: Results of the GCT-99 Protocol From the Brazilian Germ Cell Pediatric Oncology Cooperative Group.
Lopes LF; Macedo CR; Aguiar Sdos S; Barreto JH; Martins GE; Sonaglio V; Milone M; Lima ER; Almeida MT; Lopes PM; Watanabe FM; D'Andrea ML; Pianovski MA; Melaragno R; Vianna SM; Moreira ME; Bruniera P; de Oliveira CZ
J Clin Oncol; 2016 Feb; 34(6):603-10. PubMed ID: 26729441
[TBL] [Abstract][Full Text] [Related]
19. Serum lactate dehydrogenase isoenzyme 1 and prediction of death in patients with metastatic testicular germ cell tumors.
von Eyben FE; Blaabjerg O; Hyltoft-Petersen P; Madsen EL; Amato R; Liu F; Fritsche H
Clin Chem Lab Med; 2001 Jan; 39(1):38-44. PubMed ID: 11256799
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in children with localized malignant nonseminomatous germ cell tumors.
Baranzelli MC; Kramar A; Bouffet E; Quintana E; Rubie H; Edan C; Patte C
J Clin Oncol; 1999 Apr; 17(4):1212. PubMed ID: 10561181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
